MELBOURNE, Australia–(BUSINESS WIRE)–Medical device company dorsaVi Ltd (ASX:DVL) has received 510(k) clearance by the US Food and Drug Administration expanding the use of ViMove in the United States. The expanded […]
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00Business Wirehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBusiness Wire2015-06-01 00:05:002015-06-08 21:02:16FDA Approves ViMove for Expanded Use in the United States